Uhmontpellier
Montpellier, 34295, France
NCT Number: NCT04662268
Our objective is to determine a prognostic score including CT, clinical and biological criteria predicting the serious (death / surgery) or non-serious (medical treatment) evolution of ischemic colitis and therefore possibly modify the therapeutic management (propose surgical treatment for a severe form based on prognostic score).
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Montpellier, 34295, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 1 day
Severe (surgery and/or death) or non severe form of ischemic colitis (medical treatment) : analysis of radiological, biological and clinical data is performed at the time of acute episode of ischemic colitis when the patient is admitted to the hospital or during the stay of the patient previously present in the hospital for another condition
University Hospital, Montpellier
Other
Assessment of a Composite Prognostic Score to Predict Severe Forms of Ischemic Colitis of Montpellier
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00534131
Cardiovascular Diseases, Colitis
London, England, United Kingdom
View Trial DetailsNCT01078324
Cardiovascular Diseases, Colitis
Los Angeles, California, United States
View Trial DetailsNCT06488703
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Asthma
Germany
View Trial DetailsNCT03835780
Arthritis, Arthritis, Psoriatic
London, United Kingdom
View Trial Details